| Adjuvants are key factors for the development of future vaccines: lessons from the Finlay adjuvant platform O Pérez, B Romeu, O Cabrera, E González, A Batista-Duharte, A Labrada, ... Frontiers in immunology 4, 407, 2013 | 80 | 2013 |
| Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice R Acevedo, A Callicó, J Del Campo, E González, B Cedré, L González, ... Methods 49 (4), 309-315, 2009 | 46 | 2009 |
| Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses J Del Campo, C Zayas, B Romeu, R Acevedo, E González, G Bracho, ... Methods 49 (4), 301-308, 2009 | 45 | 2009 |
| Mucosal approaches in Neisseria vaccinology J Balboa, B Romeu, M Baró, C Campa, MI Lantero, G Sierra, MA Galindo, ... VacciMonitor 18 (2), 53-55, 2009 | 42 | 2009 |
| Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii A Batista-Duharte, M Lastre, B Romeu, DL Portuondo, D Téllez-Martínez, ... International Immunopharmacology 40, 277-287, 2016 | 28 | 2016 |
| Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non … B Romeu, M Lastre, L García, B Cedré, A Mandariote, M Fariñas, R Oliva, ... Immunologic research 58, 75-85, 2014 | 24 | 2014 |
| Inmunopotenciadores para la acuicultura R Pérez, B Romeu, M Lastre, Y Morales, O Cabrera, L Reyes, E González, ... VacciMonitor 23 (1), 24-31, 2014 | 14 | 2014 |
| Meningococcal disease in North America: updates from the global meningococcal initiative EJ Asturias, X Bai, JA Bettinger, R Borrow, DN Castillo, DA Caugant, ... Journal of Infection 85 (6), 611-622, 2022 | 12 | 2022 |
| Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B C Zayas, D González, R Acevedo, J Del Campo, M Lastre, E González, ... BMC immunology 14, 1-5, 2013 | 11 | 2013 |
| AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses B Romeu, E González, C Zayas, JD Campo, R Acevedo, M Cuello, ... Scandinavian journal of infectious diseases 43 (10), 809-813, 2011 | 11 | 2011 |
| Mucosal and systemic immune responses induced by a single time vaccination strategy in mice E González Aznar, B Romeu, M Lastre, C Zayas, M Cuello, O Cabrera, ... Canadian journal of microbiology 61 (8), 531-538, 2015 | 10 | 2015 |
| Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses B Romeu, M Lastre, L Reyes, E González, Y Borrero, D Lescaille, R Pérez, ... Vaccine 32 (51), 6971-6978, 2014 | 10 | 2014 |
| Single-time vaccines OGP Martin, EA Gonzalez, BA Romeu, JMDC Alonso, RG Acevedo, ... US Patent App. 13/130,146, 2011 | 9 | 2011 |
| Mucosal and systemic immune response against Neisseria meningitidis B induced by single time vaccination strategy N Nuñez, Y Valdez, M Fariñas, O Pérez, E González, B Romeu, ... VacciMonitor 18 (2), 73-75, 2009 | 9 | 2009 |
| Nasal immunization with AFCo1 induces immune response to N. gonorrhoea in mice B Romeu, K Thörn, M Lindqvist, J Persson, AM Harandi, O Pérez, ... Vaccimonitor 18 (2), 76-78, 2009 | 8 | 2009 |
| Adjuvants are key factors for the development of future vaccines: lessons from the finlay adjuvant platform. Front Immunol 4: 407 O Pérez, B Romeu, O Cabrera, E González, A Batista-Duharte, A Labrada, ... | 7 | 2013 |
| Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1 B Romeu, E Gonzalez, J Del Campo, R Acevedo, C Zayas, Y Valdes, ... Canadian journal of microbiology 57 (3), 256-261, 2011 | 7 | 2011 |
| Proteoliposome and polysaccharide-based meningococcal vaccine are immunogenic in infants and toddlers and primes for memory against serogroup C polysaccharide O Pérez, B Romeu, J del Campo, C Zayas, M Lastre Scientific Research Publishing, 2013 | 5 | 2013 |
| Vacunas unitemporales O Pérez, E González, B Romeu, JM Del Campo, R Acevedo, M Lastre, ... Cuba patente OCPI: CU20080215 y WO2010057447A1, 2009 | 5 | 2009 |
| Vacunas unitemporales. Patent applied OCPI O Pérez, E González, B Romeu, J del Campo, R Acevedo, M Lastre CU/P/2008/215. November 19, 2008 | 5 | 2008 |
